SYRS Similar Chart Price Prediction
The price of SYRS is predicted to go up -14.56%, based on the high correlation periods with LDWY. The similarity of these two price pattern on the periods is 97.71%.
SYRS
LDWY
Down: -14.56%Similarity: 97.71%
SYRS Revenue Forecast
SYRS EPS Forecast
SYRS FAQs
What is SYRS eps forecast for next quarter？
The market consensus for SYRS's eps in the upcoming quarter is projected to be approximately $0.70 USD.
SYRS Analyst's Forecast
Phil Nadeau
TD Cowen
Strong Buy → Hold
2024-11-13
Price Target
n/a
Downside
0%
TD Cowen analyst Phil Nadeau downgraded Syros Pharmaceuticals to Hold from Buy after the company announced that the SELECT-MDS-1 Phase 3 trial failed to meet its primary endpoint and the trial is being discontinued. The firm has removed all tamibarotene estimates from its model, noting that the failure of SELECT-MDS-1 ends Syros' last active clinical program and triggers an event of default under the terms of the company's secured loan facility with Oxford Finance.
Jason Butler
JMP Securities
Buy → Hold
2024-11-13
Price Target
n/a
Downside
0%
Leah Rush
Brookline Capital
Strong Buy → Hold
2024-11-13
Price Target
n/a
Downside
0%
